VaramirStart free · no cardSign in
PRME as of Oct 31 · 00:05 ET
PRMENasdaqBiological Products, (No Diagnostic Substances)

Prime Medicine, Inc. · Brief

Next report

6 days

Nov 6 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±18.1%
avg realized
±7.5%
Nov 12 '24±13.5%▼−8.33%×0.62
Feb 28 '25±19.6%▲+4.13%×0.21
May 8 '25±32.5%▼−7.04%×0.22
Aug 7 '25±13.6%▼−9.58%×0.71
Q3 FY25±17.6%▼−8.85%×0.50
Q1 FY26±18.4%▼−9.23%×0.50
May 7 '26±15.5%▼−8.65%×0.56
Q2 FY26±14.2%▼−4.22%×0.30
quarterimplied−35%0+35%realized×
Q2 FY26±14.2%▼−4.22%×0.30
May '26±15.5%▼−8.65%×0.56
Q1 FY26±18.4%▼−9.23%×0.50
Q3 FY25±17.6%▼−8.85%×0.50
Aug '25±13.6%▼−9.58%×0.71
May '25±32.5%▼−7.04%×0.22
2 older reports
Feb '25±19.6%▲+4.13%×0.21
Nov '24±13.5%▼−8.33%×0.62
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 6 report · est.

Bull2 of 3

12disclosed supplier and customer ties in SEC filingsSEC filings
186managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

8 of 8recent reports where the move came in under the options implied rangeEarnings history
4tracked funds holding PRMEN-PORT · Aug 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

PRME report session

Customers 1

BEAMBeam×0.44
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 23impliedImplied move: ±21.7% into Nov 6 earnings (Oct 23 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.